Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2024 Oct 24;9(11):5770–5775. doi: 10.1021/acssensors.4c01895

A Reactive and Specific Sensor for Activity-Based 19F-MRI Sensing of Zn2+

Lucia M Lee †,, Nishanth D Tirukoti †,§, Balamurugan Subramani , Elad Goren , Yael Diskin-Posner , Hyla Allouche-Arnon , Amnon Bar-Shir †,*
PMCID: PMC11590105  PMID: 39445901

Abstract

graphic file with name se4c01895_0006.jpg

The rapid fluctuations of metal ion levels in biological systems are faster than the time needed to map fluorinated sensors designed for the 19F-MRI of cations. An attractive modular solution might come from the activity-based sensing approach. Here, we propose a highly reactive but still ultimately specific synthetic fluorinated sensor for 19F-MRI mapping of labile Zn2+. The sensor comprises a dipicolylamine scaffold for Zn2+ recognition conjugated to a fluorophenyl acetate entity. Upon binding to Zn2+, the synthetic sensor is readily hydrolyzed, and the frequency of its 19F-functional group in 19F-NMR is shifted by 12 ppm, allowing the display of the Zn2+ distribution as an artificial MRI-colored map highlighting its specificity compared to other metal ions. The irreversible Zn2+-induced hydrolysis results in a “turn-on” 19F-MRI, potentially detecting the cation even upon a transient elevation of its levels. We envision that additional metal-ion sensors can be developed based on the principles demonstrated in this work, expanding the molecular toolbox currently used for 19F-MRI.

Keywords: 19F-MRI, Zn2+ imaging, Activity Based Sensing, Responsive Agents, Metal Ion Sensing


The vast majority of imaging probes developed for metal ion sensing comprise two entities: a multidentate organic ligand for cation recognition and binding, and an imageable entity that generates a readable signal.1,2 Adopting this design principle, responsive paramagnetic contrast agents were developed to monitor labile cations with magnetic resonance imaging (MRI),38 overcoming the restrictions of fluorescent imaging and enabling in vivo investigation of metal ions in deep tissues. In these agents, the ion recognition entity, which participates in the paramagnetic metal coordination, binds the cation of interest, freeing the paramagnetic center to bind water molecules, thus inducing paramagnetic relaxation enhancement and a change in the MRI contrast.9 Optimization of the structural and binding properties of such MRI-responsive agents allowed spatial mapping of dynamic changes in Ca2+ levels in the brain,1013 Cu2+ in the liver,14 and Zn2+ in pancreatic1517 and prostate18,19 tissues in vivo. While these designs benefit from high sensitivity, relying on two different molecular entities, one for cation binding and one for MRI signal amplification, limits the flexibility of the sensor architecture. In addition, the large 1H-MRI signal of the surrounding tissue may complicate the interpretation of results and their quantification when using paramagnetic contrast agents.

Fluorinated ligands were proposed as an alternative type of cation sensor where the ion-binding entity also serves the signal generator, aiming to overcome some of these limitations.20 With this type of sensor, upon binding the cation of interest, a significant chemical shift offset in the 19F-NMR spectrum is obtained with a unique MR fingerprint for each ion, allowing the monitoring of multiple ions simultaneously with the aid of a single sensor. Extending this approach for 19F-MRI studies, combined with the chemical exchange saturation transfer (CEST) contrast mechanism21,22 has shown promise for noninvasive in vivo mapping of labile Zn2+ in prostate23 and brain24 tissues. Although fluorinated agents provide background-free maps and quantifiable information, which do not apply to paramagnetic MRI-responsive agents, the time needed to acquire their signal is expected to be longer than the changes in metal ion levels in biological systems, thus calling for advances for this group of sensors.

An emerging concept for sensing, which relies on the reactivity of the sensor rather than on molecular recognition and reversible binding, may overcome some of the remaining challenges for the 19F-MRI of metal ions. In this approach, activity-based sensing (ABS),25 the analyte identification occurs via an analyte-initiated reaction, after which a detectable signal is generated.2629 Applying the ABS principles to 19F-MRI has shown potential for mapping the activity of several key enzymes3032 and biologically relevant redox conditions.33,34 The irreversible rapid change in the 19F-MR properties of the sensor upon conversion creates “turn-on” MRI signals that can be repeatedly acquired, thus overcoming the relatively low sensitivity of the 19F-MRI approach, which frequently requires long acquisition times. Recognizing the need for advanced and specific MRI-responsive agents for metal ions with biological relevance, we propose a highly reactive but still very specific sensor for the 19F-MRI mapping of labile Zn2+. Upon binding to Zn2+, the synthetic sensor is readily hydrolyzed, and the resonance of its 19F-functional group is shifted by 12 ppm, allowing the display of the Zn2+ distribution as an artificial MRI-colored map highlighting its ultimate specificity.

Aiming to obtain a sensor with specific 19F-NMR properties that shows a different 19F-NMR chemical shift (Δω) upon Zn2+-catalyzed hydrolysis, a fluorinated molecular probe was proposed (Figure 1a,b). To this end, a dipicolylamine (DPA) scaffold was used as a zinc-recognition entity conjugated to a fluorinated phenyl acetate moiety. Based on previous designs, we hypothesized that upon binding to a DPA entity,26 the intramolecular interactions between the bound Zn2+ and the acetate’s carbonyl group, along with the Lewis acidity of the ion, would catalyze the hydrolysis of the ester. This hydrolysis is expected to result in a much more stable phenolic complex of Zn2+ and induce a change in the 19F-NMR chemical shift of the probe. Two sensors were obtained, each with an acetate functional group at the phenyl ring and a fluorine substitution at either the meta-position (1-OAc) or the para-position (2-OAc), relative to the acetate group. Then, aqueous solutions of the two sensors were subjected to 19F-NMR measurements without or with the addition of Zn2+. Upon Zn2+-induced hydrolysis of the acetate group in 1-OAc, only a small change in the 19F-NMR chemical shift (Δω = 0.3 ppm) was observed from the resulting 1-OH-Zn2+ complex (Figure 1c). In contrast, a significantly large Δω of 12 ppm was detected in the 19F-NMR spectrum after the hydrolysis of 2-OAc to 2-OH in the presence of Zn2+ (Figure 1d). This large Δω, which was applicable for 19F-MR sensing of Zn2+ based on reversible binding,35 allows a clear separation between the two forms of the sensor before and after Zn2+-induced hydrolysis.

Figure 1.

Figure 1

Zn2+ sensor synthesis and mode of action. (a) The synthetic route for synthesizing 1-OAc and 2-OAc. (b) Illustration of the sensor hydrolysis and its mode of action. (c) 19F-NMR spectra of 1-OAc (labeled green) and the obtained 1-OH-Zn2+ complex (labeled red) upon hydrolysis, with the chemical shift offset between the two forms, Δω = 0.3 ppm(d) 19F-NMR spectra of 2-OAc (labeled green) and the obtained 2-OH-Zn2+ complex (labeled red), Δω = 12 ppm.

The white-transparent crystals of the Zn2+-complexes were obtained by crystallizing either 1-OH or 2-OH in the presence of Zn(ClO4)·6H2O in methanol at ambient temperature, and the solid-state structures of the complexes of 1-OH and 2-OH with Zn2+ were obtained and studied (Figures 2, S1, and S2 and Table S1).

Figure 2.

Figure 2

Crystal structures of complexes of Zn2+ with 1-OH and 2-OH. The ORTEP schemes for the dimers obtained are shown in (a) 1-OH-Zn2+ and (b) 2-OH-Zn2+. Displacement ellipsoids are shown at the 50% probability level, and hydrogen atoms have been omitted for the sake of clarity. Color codes: F (purple), O (red), N (blue), and Zn2+ (pink).

X-ray crystallography revealed a dimeric structure for both the 1-OH-Zn2+ and 2-OH-Zn2+ complexes. In 2-OH-Zn2+, the preferable molecule for 19F-MRI (Figure 1d), the Zn2+ center is coordinated to three nitrogen atoms from the dicopylamine and two bridging oxygen atoms of fluoro-phenols. The Zn–N bond lengths range between 2.054(2) Å, 2.056(2) Å, and 2.165(2) Å, while the Zn–O bond lengths are 1.995(2) Å, comparable to those found in a previously reported Zn2+ fluorescent sensor,36 demonstrating the strong coordination ability of 2-OH’s to the Lewis acidic Zn2+ ions in 2-OH-Zn2+.

The specificity of the 2-OAc for Zn2+ sensing was examined with potentially competitive cations (Figure S3), and the 19F-NMR spectra of the 2-OAc solution in the presence of Ca2+, Mg2+, Cu2+, Fe2+, Fe3+, Mn2+, Ni2+, Co2+, Na+, or K+ were compared to its spectrum in the presence of Zn2+. Notably, only the Zn2+-containing solution yielded a characteristic 19F-NMR peak at −129 ppm, which is assigned to the 2-OH-Zn2+ complex. No significant 19F-NMR peak could be assigned to a 2-OH-M+ complex in the solution for all of the other studied cations. For the paramagnetic cations examined, either a small shift or a line-broadening could be detected for the 19F-NMR peak of the fluorinated sensor.

Then, the kinetic properties of the 2-OAc hydrolysis in the presence of Zn2+ were compared to that of Ca2+, Cu2+, and Fe2+ (Figure 3 and Figure S4). To this end, buffered (HEPES buffer, pH 7.2) solutions of 3 mM 2-OAc in equimolar cation concentrations were prepared, and consecutive 19F-NMR spectra were measured. Clearly, 10 min after the Zn2+ addition, when the acquisition of the first 19F-NMR was completed, a peak at −129 ppm, a characteristic resonance of the 2-OH-Zn2+ complex, was already obtained (Figure 3a and Figure S4a). Over time, the intensity of the 19F-NMR peak of 2-OAc (−117 ppm) was reduced until its elimination, while the intensity peak of the 2-OH-Zn2+ complex was elevated as expected from continuous hydrolysis of 2-OAc by the labile-free Zn2+ in the solution. This observation was not detected in the presence of the other cations studied (Figure 3b–d, Figure S4b–d). Even for ions expecting to bind a dipicolylamine scaffold, such as Fe2+ and Cu2+,37 although some paramagnetic line-broadening and reduction in the intensity of the 2-OAc peak were obtained over time, no evidence of 2-OH complexes in the presence of these cations was shown by 19F-NMR (Figure 3c,d and Figure S4). Still, traces of such complexes were identified by mass spectroscopy measurements (Figures S5–S7). Importantly, even at a much lower Zn2+ concentration, a pronounced peak at the resonance of the 2-OH-Zn2+ complex (−129 ppm) could be detected in addition to the nonhydrolyzed 2-OAc compound with its characteristic peak at −117 ppm (Figure S8). Notably, in this case, when the concentration of Zn2+ was lower than that of the 2-OAc compound, an additional peak of the hydrolyzed 2-OH compound without Zn2+ bound to it was detected at −126 ppm. This observation could be explained by the reversible binding of Zn2+ to 2-OH.

Figure 3.

Figure 3

Fluorinated sensor specificity. Real-time 19F NMR spectra of 2-OAc in the presence of (a) Zn2+, (b) Ca2+, (c) Cu2+, and (d) Fe2+. The green rectangle marks the chemical shift of 2-OAc (−117 ppm), and the red rectangle marks the chemical shift of 2-OH-Zn2+ (−129 ppm).

The kinetic profile of Zn2+-induced hydrolysis of 2-OAc was studied by 19F-NMR (Figure 4). The half lifetime (t1/2) of 2-OAc in the presence of Zn2+ was then evaluated by plotting the integrals of the two obtaining peaks at the 19F-NMR spectra, −117 ppm before Zn2+-induced hydrolysis and −129 ppm after the hydrolysis. The t1/2 of 2-OAc in the presence of Zn2+ at 25 °C was 9 min (Figure 4a,d) while that at 37 °C was 4 min (Figure 4b,d and Figure S9). Importantly, with the addition of 3 mM Ca2+, the t1/2 of 2-OAc was found to be longer than 30 h, reflecting the sensor stability in an aqueous solution and its specificity for Zn2+ (Figure 4c and Figure S10). At acidic conditions (pH = 6.5), although slower than at physiological pH, the t1/2 of 2-OAc in the presence of Zn2+ (at 37 °C) was still relatively short (t1/2 = 9 min, Figure S11). As expected, the Zn2+-induced hydrolysis was faster in alkaline conditions at physiological temperature, with a 100% conversion of 2-OAc to 2-OH before the acquisition of the first 19F-NMR spectrum was completed (Figure S11). Prominently, under strong basic conditions (pH = 8.5), no hydrolysis of 2-OAc occurred without Zn2+, showing the cruciality of the ion in the reaction and the stability of 2-OAc even at an elevated pH (Figure S12).

Figure 4.

Figure 4

Kinetic studies of the 2-OAc activity. 19F-NMR signal intensity representing the conversion of 2-OAc (green dots, 19F-NMR peak at −117 ppm) to 2-OH (red dots, 19F-NMR peak at −129 ppm) in the presence of Zn2+ at (a) 25 or (b) 37 °C; or in the presence of (c) Ca2+ at 25 °C. (d) The t1/2 values of 2-OAc as evaluated from the plots in panels a–c.

Similar observations were obtained when the same assay was performed in a cell culture medium (DMEM) containing physiologically relevant concentrations of nucleophilic metabolites (sugars, amino acids, and salts) and 10% fetal bovine serum albumin (FBS). Remarkably, when such a medium contained Zn2+, 2-OAc was hydrolyzed entirely before the first 19F-NMR spectrum was acquired (Figure S13). This contrasts with the exact solution of 2-OAc, to which Zn2+ was not added, where even at 37 °C, only a slight hydrolysis of 2-OAc could be detected after 1 h (Figure S14). This observation that serum albumin content accelerates the Zn2+-induced hydrolysis of 2-OAc, should be further studied. Nevertheless, it could be attributed to the serum albumin’s ability to stabilize Zn2+-bound DPA scaffolds, as previously reported.4 This stabilization might strengthen the intramolecular interactions between the bound Zn2+ and the acetate’s carbonyl group, thereby accelerating the ester hydrolysis due to the proximity of the Lewis acid (bound Zn2+) in the formed 2-OAc-Zn2+ complex. Overall, these results show the stability of 2-OAc in the absence of Zn2+, regardless of the solution conditions with no apparent hydrolysis without the ion at elevated temperature, alkaline conditions, and the presence of high concentration of nucleophiles and serum protein assuring that the proposed sensor will be stable in a biological environment.

Finally, we set out to examine the ability to map the presence of 2-OAc with 19F-MRI and present its Zn2+-sensing capabilities in a multiplex manner based on the large chemical shifts of the sensor before and after its hydrolysis. For that purpose, a phantom of six tubes containing 3 mM 2-OAc and an equimolar of a different cation (one tube was used as a negative control without cation addition) was set and studied. Figure 5a shows the 19F-NMR spectra of five tubes containing 2-OAc and a cation in HEPES buffered solution (pH = 7.2). As clearly shown, only for the solution that contained Zn2+ a 19F-NMR peak was observed at −129 ppm, as expected from a 2-OH-Zn2+ complex, reflecting the “turn-on” 19F-MR feature of the Zn2+ sensor. A single and clear peak is obtained for all other tubes with a resonance of −117 ppm, reflecting intact, nonhydrolyzed 2-OAc in the studied solution. 1H-MRI of the studied phantom showed no difference between the tubes (Figure 5b).

Figure 5.

Figure 5

Multiplexed 19F-MRI of Zn2+ sensing. (a) 19F NMR spectra of 3 mM 2-OAc in the presence of 3 mM Zn2+, Ca2+, K+, Mg2+ and Na+ at 37 °C. (b) 1H-MRI (left) of the studied phantom composed of six tubes containing 3 mM 2-OAc and 3 mM cation, i.e., K+ (#1), Ca2+(#2), Zn2+(#3), Na+ (#5), and Mg2+ (#6). Tube #4 contained only 2-OAc. 19F-MRI map as obtained with the O1 set to −117 ppm (middle panel, green) and or −129 ppm (right panel, red).

When 19F-MRI data was acquired with the center frequency (O1) set to the resonance of 2-OAc, i.e., 117 ppm, a clear signal was obtained from 5 out of the 6 studied tubes. In contrast, setting up the O1 of the 19F-MRI acquisition protocol to 129 ppm, a 19F-MR signal was obtained only from the tube containing Zn2+, a clear indication of the complex of the cation with 2-OH. In contrast to the 19F-CEST approach, which requires the acquisition of at least two 19F-MR images for Zn2+ mapping (“on-resonance” and “off-resonance”),24 the approach presented here can provide 19F-MR map of Zn2+ distribution by setting up the O1 of the 19F-MRI acquisition protocol to −129 ppm and acquiring a single 19F-MR image.

In addition to this advantage, the large Δω of 12 ppm between in the 19F-MR resonances of nonhydrolyzed 2-OAc and the Zn2+ complex of the sensor after its hydrolysis to 2-OH allowed us to present the results in artificial MRI colors, with green representing the 19F-MRI map at −117 ppm and red representing the 19F-MRI map at −129 ppm. This frequency encoding feature resulting in multicolor representations of different species is unique to 19F-MRI studies and is useful for mapping multiple targets in the same region of interest,38 but it can also be used for other applications.3941 To summarize this part, we showed that 2-OAc could be used as a sensor for activity-based 19F-MRI mapping of Zn2+ with the capability to present the existence of the cation in artificially colored MRI maps capitalizing on the distinctive chemical shift of the resulted 2-OH-Zn2+ complex.

In conclusion, we demonstrated a conceptually novel approach for MRI sensing of labile Zn2+, which relies on ABS principles. Specifically, having designed a fluorine-modified phenyl acetate moiety attached to a dipicolylamine motif, a Zn2+ sensitive 19F-MRI sensor (2-OAc) was obtained. We showed that upon Zn2+ recognition and binding, 2-OAc readily undergoes hydrolysis to result in the 2-OH-Zn2+ complex. The large 19F-NMR Δω difference between the resonances of 2-OAc and that of 2-OH-Zn2+ allows one to spectrally resolve them toward their presentation in a dual-color 19F-MRI fashion, obtaining a “turn-on” 19F-MRI sensor for Zn2+. The high specificity and reactivity of 2-OAc only in the presence of Zn2+ to obtain, nonreversibly, 2-OH makes the proposed strategy advantageous for 19F-MRI, which frequently requires acquisition times much longer than the time dynamic biological processes occur. We envision that the principles shown in this work for ABS 19F-MRI sensing of Zn2+ could be generalized for imaging other metal ions.

Data Availability Statement

CCDC 2366644–2366645 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_requests/cif, by emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: + 44 1223 336033.

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acssensors.4c01895.

  • Sensors synthesis and characterizations are provided, along with additional experimental methods and supporting figures (PDF)

Author Contributions

The manuscript was written with contributions from all authors. All authors have given approval to the final version of the manuscript.

This project was funded from the European Research Council under the European Union’s Horizon 2020 research and innovation program (grant No. 101086836) and the Israel Science Foundation (grant No. 1329/20). L.M.L thanks the Zuckerman Postdoctoral Scholars Program.

The authors declare no competing financial interest.

Supplementary Material

se4c01895_si_001.pdf (8.1MB, pdf)

References

  1. Carter K. P.; Young A. M.; Palmer A. E. Fluorescent sensors for measuring metal ions in living systems. Chem. Rev. 2014, 114 (8), 4564–601. 10.1021/cr400546e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Domaille D. W.; Que E. L.; Chang C. J. Synthetic fluorescent sensors for studying the cell biology of metals. Nat. Chem. Biol. 2008, 4 (3), 168–75. 10.1038/nchembio.69. [DOI] [PubMed] [Google Scholar]
  3. Li W.-h.; Fraser S. E.; Meade T. J. A Calcium-Sensitive Magnetic Resonance Imaging Contrast Agent. J. Am. Chem. Soc. 1999, 121 (6), 1413–1414. 10.1021/ja983702l. [DOI] [Google Scholar]
  4. Esqueda A. C.; Lopez J. A.; Andreu-de-Riquer G.; Alvarado-Monzon J. C.; Ratnakar J.; Lubag A. J.; Sherry A. D.; De Leon-Rodriguez L. M. A new gadolinium-based MRI zinc sensor. J. Am. Chem. Soc. 2009, 131 (32), 11387–91. 10.1021/ja901875v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hanaoka K.; Kikuchi K.; Urano Y.; Narazaki M.; Yokawa T.; Sakamoto S.; Yamaguchi K.; Nagano T. Design and synthesis of a novel magnetic resonance imaging contrast agent for selective sensing of zinc ion. Chem. Biol. 2002, 9 (9), 1027–32. 10.1016/S1074-5521(02)00216-8. [DOI] [PubMed] [Google Scholar]
  6. Major J. L.; Parigi G.; Luchinat C.; Meade T. J. The synthesis and in vitro testing of a zinc-activated MRI contrast agent. Proc. Natl. Acad. Sci. U. S. A. 2007, 104 (35), 13881–6. 10.1073/pnas.0706247104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Isaac M.; Pallier A.; Szeremeta F.; Bayle P.-A.; Barantin L.; Bonnet C. S.; Sénèque O. MRI and luminescence detection of Zn2+ with a lanthanide complex-zinc finger peptide conjugate. Chem. Commun. 2018, 54 (53), 7350–7353. 10.1039/C8CC04366C. [DOI] [PubMed] [Google Scholar]
  8. Srivastava K.; Ferrauto G.; Harris S. M.; Longo D. L.; Botta M.; Aime S.; Pierre V. C. Complete on/off responsive ParaCEST MRI contrast agents for copper and zinc. Dalton Trans 2018, 47 (33), 11346–11357. 10.1039/C8DT01172A. [DOI] [PubMed] [Google Scholar]
  9. Que E. L.; Chang C. J. Responsive magnetic resonance imaging contrast agents as chemical sensors for metals in biology and medicine. Chem. Soc. Rev. 2010, 39 (1), 51–60. 10.1039/B914348N. [DOI] [PubMed] [Google Scholar]
  10. Barandov A.; Bartelle B. B.; Williamson C. G.; Loucks E. S.; Lippard S. J.; Jasanoff A. Sensing intracellular calcium ions using a manganese-based MRI contrast agent. Nat. Commun. 2019, 10 (1), 897. 10.1038/s41467-019-08558-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lee T.; Zhang X. A.; Dhar S.; Faas H.; Lippard S. J.; Jasanoff A. In vivo imaging with a cell-permeable porphyrin-based MRI contrast agent. Chem. Biol. 2010, 17 (6), 665–73. 10.1016/j.chembiol.2010.05.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Okada S.; Bartelle B. B.; Li N.; Breton-Provencher V.; Lee J. J.; Rodriguez E.; Melican J.; Sur M.; Jasanoff A. Calcium-dependent molecular fMRI using a magnetic nanosensor. Nat. Nanotechnol 2018, 13 (6), 473–477. 10.1038/s41565-018-0092-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Savic T.; Gambino G.; Bokharaie V. S.; Noori H. R.; Logothetis N. K.; Angelovski G. Early detection and monitoring of cerebral ischemia using calcium-responsive MRI probes. Proc. Natl. Acad. Sci. U. S. A. 2019, 116 (41), 20666–20671. 10.1073/pnas.1908503116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Paranawithana N. N.; Martins A. F.; Clavijo Jordan V.; Zhao P.; Chirayil S.; Meloni G.; Sherry A. D. A Responsive Magnetic Resonance Imaging Contrast Agent for Detection of Excess Copper(II) in the Liver In Vivo. J. Am. Chem. Soc. 2019, 141 (28), 11009–11018. 10.1021/jacs.8b13493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lubag A. J.; De Leon-Rodriguez L. M.; Burgess S. C.; Sherry A. D. Noninvasive MRI of beta-cell function using a Zn2+-responsive contrast agent. Proc. Natl. Acad. Sci. U. S. A. 2011, 108 (45), 18400–5. 10.1073/pnas.1109649108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Martins A. F.; Clavijo Jordan V.; Bochner F.; Chirayil S.; Paranawithana N.; Zhang S.; Lo S. T.; Wen X.; Zhao P.; Neeman M.; Sherry A. D. Imaging Insulin Secretion from Mouse Pancreas by MRI Is Improved by Use of a Zinc-Responsive MRI Sensor with Lower Affinity for Zn2+ Ions. J. Am. Chem. Soc. 2018, 140 (50), 17456–17464. 10.1021/jacs.8b07607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Stasiuk G. J.; Minuzzi F.; Sae-Heng M.; Rivas C.; Juretschke H.-P.; Piemonti L.; Allegrini P. R.; Laurent D.; Duckworth A. R.; Beeby A.; Rutter G. A.; Long N. J. Dual-Modal Magnetic Resonance/Fluorescent Zinc Probes for Pancreatic β-Cell Mass Imaging. Chem. Eur. J. 2015, 21 (13), 5023–5033. 10.1002/chem.201406008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Clavijo Jordan M. V.; Lo S. T.; Chen S.; Preihs C.; Chirayil S.; Zhang S.; Kapur P.; Li W. H.; De Leon-Rodriguez L. M.; Lubag A. J.; Rofsky N. M.; Sherry A. D. Zinc-sensitive MRI contrast agent detects differential release of Zn(II) ions from the healthy vs. malignant mouse prostate. Proc. Natl. Acad. Sci. U. S. A. 2016, 113 (37), E5464–71. 10.1073/pnas.1609450113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Clavijo Jordan V.; Hines C. D. G.; Gantert L. T.; Wang S.; Conarello S.; Preihs C.; Chirayil S.; Klimas M.; Evelhoch J. L.; Sherry A. D. Imaging Beta-Cell Function in the Pancreas of Non-Human Primates Using a Zinc-Sensitive MRI Contrast Agent. Front Endocrinol 2021, 12, 641722. 10.3389/fendo.2021.641722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Smith G. A.; Hesketh R. T.; Metcalfe J. C.; Feeney J.; Morris P. G. Intracellular calcium measurements by 19F NMR of fluorine-labeled chelators. Proc. Natl. Acad. Sci. U. S. A. 1983, 80 (23), 7178–82. 10.1073/pnas.80.23.7178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Bar-Shir A.; Gilad A. A.; Chan K. W.; Liu G.; van Zijl P. C.; Bulte J. W.; McMahon M. T. Metal ion sensing using ion chemical exchange saturation transfer 19F magnetic resonance imaging. J. Am. Chem. Soc. 2013, 135 (33), 12164–7. 10.1021/ja403542g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Bar-Shir A.; Yadav N. N.; Gilad A. A.; van Zijl P. C.; McMahon M. T.; Bulte J. W. Single (19)F probe for simultaneous detection of multiple metal ions using miCEST MRI. J. Am. Chem. Soc. 2015, 137 (1), 78–81. 10.1021/ja511313k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Yuan Y.; Wei Z.; Chu C.; Zhang J.; Song X.; Walczak P.; Bulte J. W. M. Development of Zinc-Specific iCEST MRI as an Imaging Biomarker for Prostate Cancer. Angew. Chem., Int. Ed. Engl. 2019, 58 (43), 15512–15517. 10.1002/anie.201909429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tirukoti N. D.; Avram L.; Haris T.; Lerner B.; Diskin-Posner Y.; Allouche-Arnon H.; Bar-Shir A. Fast Ion-Chelate Dissociation Rate for In Vivo MRI of Labile Zinc with Frequency-Specific Encodability. J. Am. Chem. Soc. 2021, 143 (30), 11751–11758. 10.1021/jacs.1c05376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Chang C. J.; James T. D.; New E. J.; Tang B. Z. Activity-Based Sensing: Achieving Chemical Selectivity through Chemical Reactivity. Acc. Chem. Res. 2020, 53 (1), 1–1. 10.1021/acs.accounts.9b00542. [DOI] [PubMed] [Google Scholar]
  26. Zastrow M. L.; Radford R. J.; Chyan W.; Anderson C. T.; Zhang D. Y.; Loas A.; Tzounopoulos T.; Lippard S. J. Reaction-Based Probes for Imaging Mobile Zinc in Live Cells and Tissues. ACS Sensors 2016, 1 (1), 32–39. 10.1021/acssensors.5b00022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lee S.; Chung C. Y.-S.; Liu P.; Craciun L.; Nishikawa Y.; Bruemmer K. J.; Hamachi I.; Saijo K.; Miller E. W.; Chang C. J. Activity-Based Sensing with a Metal-Directed Acyl Imidazole Strategy Reveals Cell Type-Dependent Pools of Labile Brain Copper. J. Am. Chem. Soc. 2020, 142 (35), 14993–15003. 10.1021/jacs.0c05727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Au-Yeung H. Y.; Chan J.; Chantarojsiri T.; Chang C. J. Molecular Imaging of Labile Iron(II) Pools in Living Cells with a Turn-On Fluorescent Probe. J. Am. Chem. Soc. 2013, 135 (40), 15165–15173. 10.1021/ja4072964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ko S.-K.; Yang Y.-K.; Tae J.; Shin I. In Vivo Monitoring of Mercury Ions Using a Rhodamine-Based Molecular Probe. J. Am. Chem. Soc. 2006, 128 (43), 14150–14155. 10.1021/ja065114a. [DOI] [PubMed] [Google Scholar]
  30. Yu J.; Otten P.; Ma Z.; Cui W.; Liu L.; Mason R. P. Novel NMR platform for detecting gene transfection: synthesis and evaluation of fluorinated phenyl beta-D-galactosides with potential application for assessing LacZ gene expression. Bioconjug Chem. 2004, 15 (6), 1334–41. 10.1021/bc049936d. [DOI] [PubMed] [Google Scholar]
  31. Akazawa K.; Sugihara F.; Nakamura T.; Mizukami S.; Kikuchi K. Highly Sensitive Detection of Caspase-3/7 Activity in Living Mice Using Enzyme-Responsive 19F MRI Nanoprobes. Bioconjug Chem. 2018, 29 (5), 1720–1728. 10.1021/acs.bioconjchem.8b00167. [DOI] [PubMed] [Google Scholar]
  32. Mizukami S.; Takikawa R.; Sugihara F.; Hori Y.; Tochio H.; Walchli M.; Shirakawa M.; Kikuchi K. Paramagnetic relaxation-based 19F MRI probe to detect protease activity. J. Am. Chem. Soc. 2008, 130 (3), 794–5. 10.1021/ja077058z. [DOI] [PubMed] [Google Scholar]
  33. Nakamura T.; Matsushita H.; Sugihara F.; Yoshioka Y.; Mizukami S.; Kikuchi K. Activatable 19F MRI nanoparticle probes for the detection of reducing environments. Angew. Chem., Int. Ed. Engl. 2015, 54 (3), 1007–10. 10.1002/anie.201409365. [DOI] [PubMed] [Google Scholar]
  34. Xie D.; King T. L.; Banerjee A.; Kohli V.; Que E. L. Exploiting Copper Redox for (19)F Magnetic Resonance-Based Detection of Cellular Hypoxia. J. Am. Chem. Soc. 2016, 138 (9), 2937–40. 10.1021/jacs.5b13215. [DOI] [PubMed] [Google Scholar]
  35. Yu M.; Xie D.; Kadakia R. T.; Wang W.; Que E. L. Harnessing chemical exchange: 19F magnetic resonance OFF/ON zinc sensing with a Tm(III) complex. Chem. Commun. 2020, 56 (46), 6257–6260. 10.1039/D0CC01876G. [DOI] [PubMed] [Google Scholar]
  36. Burdette S. C.; Walkup G. K.; Spingler B.; Tsien R. Y.; Lippard S. J. Fluorescent Sensors for Zn2+ Based on a Fluorescein Platform: Synthesis, Properties and Intracellular Distribution. J. Am. Chem. Soc. 2001, 123 (32), 7831–7841. 10.1021/ja010059l. [DOI] [PubMed] [Google Scholar]
  37. Huang Z.; Luo Y.; Zhang T.; Ding Y.; Chen M.; Chen J.; Liu Q.; Huang Y.; Zhao C. A Stimuli-Responsive Small-Molecule Metal-Carrying Prochelator: A Novel Prodrug Design Strategy for Metal Complexes. Angew. Chem., Int. Ed. Engl. 2022, 61 (28), e202203500. 10.1002/anie.202203500. [DOI] [PubMed] [Google Scholar]
  38. Cohen D.; Mashiach R.; Houben L.; Galisova A.; Addadi Y.; Kain D.; Lubart A.; Blinder P.; Allouche-Arnon H.; Bar-Shir A. Glyconanofluorides as Immunotracers with a Tunable Core Composition for Sensitive Hotspot Magnetic Resonance Imaging of Inflammatory Activity. ACS Nano 2021, 15 (4), 7563–7574. 10.1021/acsnano.1c01040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Luo X.; Kang B.; Chi X.; Xiong H.; Chen D.; Fan Y.; Li L.; Chen L.; Li A.; Gao J.; Lin H. 19F Barcoding Enables Multiplex Detection of Biomarkers Associated with Organ Injury and Cancer. Angew. Chem., Int. Ed. Engl. 2022, 61 (46), e202211189. 10.1002/anie.202211189. [DOI] [PubMed] [Google Scholar]
  40. Xie D.; Yu M.; Kadakia R. T.; Que E. L. 19F Magnetic Resonance Activity-Based Sensing Using Paramagnetic Metals. Acc. Chem. Res. 2020, 53 (1), 2–10. 10.1021/acs.accounts.9b00352. [DOI] [PubMed] [Google Scholar]
  41. Li A.; Luo X.; Chen D.; Li L.; Lin H.; Gao J. Small Molecule Probes for 19F Magnetic Resonance Imaging. Anal. Chem. 2023, 95 (1), 70–82. 10.1021/acs.analchem.2c04539. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

se4c01895_si_001.pdf (8.1MB, pdf)

Data Availability Statement

CCDC 2366644–2366645 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_requests/cif, by emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: + 44 1223 336033.


Articles from ACS Sensors are provided here courtesy of American Chemical Society

RESOURCES